A decade of discoveries in cardiac biology

EN Olson - Nature medicine, 2004 - nature.com
The heart is the first organ to form in the embryo, and all subsequent events in the life of the
organism depend on its function. Inherited mutations in cardiac regulatory genes give rise to …

Catestatin: a master regulator of cardiovascular functions

SK Mahata, M Kiranmayi… - Current medicinal …, 2018 - ingentaconnect.com
Background: Cardiovascular disease (CVD), the most common cause of death globally,
accounts for~ 30% of all deaths worldwide. Hypertension is a common contributor to …

Manipulating cardiac contractility in heart failure: data from mice and men

GW Dorn, JD Molkentin - Circulation, 2004 - Am Heart Assoc
both to Gαs and to the inhibitory G protein (Gαi), which functions, in part, to diminish adenylyl
cyclase activity and subsequent cAMP levels (Figure 1). The ß1-adrenergic receptor …

Phosphorylation-dependent conformational switch in spin-labeled phospholamban bound to SERCA

CB Karim, Z Zhang, EC Howard, KD Torgersen… - Journal of molecular …, 2006 - Elsevier
We have used chemical synthesis, functional reconstitution, and electron paramagnetic
resonance (EPR) to probe the functional dynamics of phospholamban (PLB), which …

Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone

CB Karim, TL Kirby, Z Zhang… - Proceedings of the …, 2004 - National Acad Sciences
We have used chemical synthesis and electron paramagnetic resonance to probe the
structural dynamics of phospholamban (PLB) in lipid bilayers. Derivatives of monomeric PLB …

Mechanisms of disease: β-adrenergic receptors—alterations in signal transduction and pharmacogenomics in heart failure

DS Feldman, CA Carnes, WT Abraham… - Nature Clinical Practice …, 2005 - nature.com
Abstract β-adrenergic signaling is an important regulator of myocardial function. During the
progression of heart failure (HF), a reproducible series of biochemical events occurs that …

[HTML][HTML] Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets

M Correale, L Tricarico, F Croella, S Alfieri… - Frontiers in …, 2023 - frontiersin.org
Despite recent advances in chronic heart failure (HF) management, the prognosis of HF
patients is poor. This highlights the need for researching new drugs targeting, beyond …

Direct detection of phospholamban and sarcoplasmic reticulum Ca-ATPase interaction in membranes using fluorescence resonance energy transfer

B Mueller, CB Karim, IV Negrashov, H Kutchai… - Biochemistry, 2004 - ACS Publications
We used fluorescence resonance energy transfer (FRET) to detect and quantitate the
interaction of the sarcoplasmic reticulum Ca-ATPase (SERCA) with phospholamban (PLB) …

Overexpression, purification, and characterization of recombinant Ca-ATPase regulators for high-resolution solution and solid-state NMR studies

B Buck, J Zamoon, TL Kirby, TM DeSilva… - Protein expression and …, 2003 - Elsevier
Phospholamban (PLB) and Sarcolipin (SLN) are integral membrane proteins that regulate
muscle contractility via direct interaction with the Ca-ATPase in cardiac and skeletal muscle …

Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging

NS Dhalla, S Rangi, AP Babick, S Zieroth… - Heart failure reviews, 2012 - Springer
Although several risk factors including hypertension, cardiac hypertrophy, coronary artery
disease, and diabetes are known to result in heart failure, elderly subjects are more …